Follow
Michael Vidne
Michael Vidne
mv333@columbia.edu
Verified email at columbia.edu
Title
Cited by
Cited by
Year
A new look at state-space models for neural data
L Paninski, Y Ahmadian, DG Ferreira, S Koyama, K Rahnama Rad, ...
Journal of computational neuroscience 29, 107-126, 2010
2512010
Modeling the impact of common noise inputs on the network activity of retinal ganglion cells
M Vidne, Y Ahmadian, J Shlens, JW Pillow, J Kulkarni, AM Litke, ...
Journal of computational neuroscience 33, 97-121, 2012
1292012
Inferring synaptic inputs given a noisy voltage trace via sequential Monte Carlo methods
L Paninski, M Vidne, B DePasquale, DG Ferreira
Journal of computational neuroscience 33, 1-19, 2012
572012
Spatial modes in a PCF fiber generated continuum
Y Vidne, M Rosenbluh
Optics Express 13 (24), 9721-9728, 2005
322005
CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement In Vitro Enabling a Novel Method for Multiplex Site-Directed Mutagenesis
BM Sansbury, AM Wagner, G Tarcic, S Barth, E Nitzan, R Goldfus, ...
The CRISPR Journal 2 (2), 121-132, 2019
192019
Inferring functional connectivity in an ensemble of retinal ganglion cells sharing a common input
M Vidne, J Kulkarni, Y Ahmadian, J Pillow, J Shlens, E Chichilnisky, ...
Frontiers in systems neuroscience conference abstract: Computational and …, 2009
182009
Comparison of ultrasonic and ophthalmoscopic evaluation of retinopathy of prematurity
DHK Jokl, RH Silverman, AD Springer, H Towers, S Kane, R Lopez, ...
Journal of Pediatric Ophthalmology & Strabismus 41 (6), 345-350, 2004
152004
Not all RAS mutations created equal: Functional and clinical characterization of 80 different KRAS and NRAS mutations.
JM Loree, B Miron, V Holla, MJ Overman, AAL Pereira, M Lam, VK Morris, ...
Journal of Clinical Oncology 35 (15_suppl), 3589-3589, 2017
132017
Revisited analysis of a SHIVA 01 trial cohort using functional mutational analyses successfully predicted treatment outcome
M Kamal, G Tarcic, S Dureau, O Edelheit, Z Barbash, C Lecerf, C Morel, ...
Molecular Oncology 12 (5), 594-601, 2018
62018
A novel system for functional determination of variants of uncertain significance using deep convolutional neural networks
L Zimmerman, O Zelichov, A Aizenmann, Z Barbash, M Vidne, G Tarcic
Scientific Reports 10 (1), 4192, 2020
52020
Robust particle filters via sequential pairwise reparameterized Gibbs sampling
L Paninski, KR Rad, M Vidne
2012 46th Annual Conference on Information Sciences and Systems (CISS), 1-6, 2012
52012
Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors
S Kato, R Porter, R Okamura, S Lee, O Zelichov, G Tarcic, M Vidne, ...
European Journal of Cancer 149, 184-192, 2021
42021
A novel high-throughput multispectral cell segmentation algorithm
J Golbstein, Y Tocker, R Sharivkin, G Tarcic, M Vidne
Medical Image Understanding and Analysis: 21st Annual Conference, MIUA 2017 …, 2017
42017
Methods and systems for determining oncogenic index of patient specific mutations
G Tarcic, Y Altschuler, M Vidne
US Patent 11,015,229, 2021
32021
Methods for in vitro site-directed mutagenesis using gene editing technologies
EB Kmiec, M Vidne, G Tarcic
US Patent App. 16/476,711, 2019
32019
Functional mutational analysis to assess the oncogenic activity of variant of uncertain significance (VUS) detected in patients included in the SHIVA trial
G Tarcic, M Kamal, O Edelheit, Z Barbash, M Vidne, B Miron, C Callens, ...
European Journal of Cancer 1 (69), S6-S7, 2016
22016
A common-input model of a complete network of ganglion cells in the primate retina
M Vidne, Y Ahmadian, J Shlens, JW Pillow, J Kulkarni, EJ Chichilnisky, ...
Computational and Systems Neuroscience, 2010
22010
Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF
F Janku, E Sherman, R Yaeger, A Parikh, R Sullivan, L Feun, MDL Fuente, ...
Cancer Research 81 (13_Supplement), CT212-CT212, 2021
12021
Functional characterization of mutations and their interaction using the novel functional annotation for cancer treatment (FACT) platform
B Miron, N Peled, Z Barbash, O Edelheit, M Vidne, R Sharivkin, G Tarcic
Annals of Oncology 27, vi404, 2016
12016
Functional profiling of oncogenic mutations in lung cancer patients (NCT02274025)-interim results
B Miron, N Peled, G Tarcic, Z Barbash, O Edelheit, M Vidne, MR Kramer
Annals of Oncology 27, vi412, 2016
12016
The system can't perform the operation now. Try again later.
Articles 1–20